COMPARISON OF IN-VITRO SUSCEPTIBILITIES OF BACTEROIDES AND FUSOBACTERIUM SPECIES IN INLAND SOUTHERN CALIFORNIA TO PUBLISHED PATTERNS AS A GUIDE TO EMPIRIC THERAPY
I. Roy et Ik. Blomquist, COMPARISON OF IN-VITRO SUSCEPTIBILITIES OF BACTEROIDES AND FUSOBACTERIUM SPECIES IN INLAND SOUTHERN CALIFORNIA TO PUBLISHED PATTERNS AS A GUIDE TO EMPIRIC THERAPY, Clinical therapeutics, 15(5), 1993, pp. 875-883
Anaerobic bacteria, particularly the Bacteroides group, are becoming i
ncreasingly resistant to antimicrobials. Anaerobic susceptibility test
ing is often not done routinely in clinical laboratories, causing clin
icians to depend on national survey results or susceptibility patterns
published by different centers. In this study, we have determined ana
erobic susceptibility patterns of 200 clinical isolates of anaerobic g
ram-negative bacilli from four hospitals in the inland counties of sou
thern California (Inland Empire). Of 11 antibiotics tested, metronidaz
ole and chloramphenicol were the most active, with no resistance noted
, followed by imipenem, ticarcillin/clavulanate, and ampicillin/sulbac
tam. Among cephalosporins, cefoxitin was the most active and cefotetan
the least. Significant differences in the susceptibility pattern to c
efoxitin were observed in one hospital. Differences between our inland
patterns and those for Los Angeles Wadsworth VA Hospital were seen fo
r cefoxitin in the B fragilis group and piperacillin for B fragilis. W
e confirmed the National Committee for Clinical Laboratory Standards (
NCCLS) recommendation for periodic determination of anaerobic suscepti
bility patterns. We also suggest that clinical laboratories routinely
identify anaerobes to the species level to facilitate clinical applica
tion of in vitro results.